Back to Alerts
🟢
Insider Buying Spree
Multiple insiders buying the same stock within a 14-day window
3+ insiders buy in 14d
30d Insider MedUp 5–6%
1yr Insider MedUp 8–9%
30d Signal Med—
1yr Signal Med—
30d Trades180
30d Insider AvgUp 18–19%
1yr Insider AvgUp 38–39%
30d Signal Avg—
1yr Signal Avg—
1yr Trades5,063
Recent Matches0 total
Range
Type
Sort
| Ticker | Insider | Title | Type | Value | Shares | Price | Insider | Signal | Date |
|---|---|---|---|---|---|---|---|---|---|
| CSGP | Glaser Rachel C | Director | BUY | $15K–$50K | 1K | $44.94 | Up 8–9% | Up 4–5% | Mar 3, 2026 |
| CSGP | SAINT FREDERICK G. | President | BUY | $500K+ | 20K | $45.33 | Up 7–8% | Up 4–5% | Mar 3, 2026 |
| MSDL | MILLER DAVID N | Director | BUY | $100K–$500K | 10K | $14.69 | Up 0–1% | Up 1–2% | Mar 3, 2026 |
| TSLX | Pluss Steven | Vice President | BUY | $100K–$500K | 15K | $17.72 | Up 4–5% | Up 3–4% | Mar 3, 2026 |
| SKWD | McHarg Taryn Leonie | CFO - Apollo | BUY | $1K–$15K | 200 | $46.60 | Up 5–6% | Up 1–2% | Mar 3, 2026 |
| AVBC | Cozzone Robert D | President & CEO | BUY | $15K–$50K | 1K | $18.79 | Up 1–2% | Up 1–2% | Mar 3, 2026 |
| AVBC | Karmelek Nicolas | EVP and CRO | BUY | $15K–$50K | 1K | $18.59 | Up 2–3% | Up 1–2% | Mar 3, 2026 |
| NFRX | Goncu Hasan Ali | Insider | BUY | $15K–$50K | 800 | $27.78 | Down 2–3% | Down 0–1% | Mar 3, 2026 |
| SKWD | Peirce Christopher Locke | Director | BUY | $100K–$500K | 3K | $47.30 | Up 3–4% | Up 1–2% | Mar 3, 2026 |
| MSDL | Occi Michael Jr. | CEO | BUY | $100K–$500K | 7K | $14.87 | Down 0–1% | Up 1–2% | Mar 3, 2026 |
| FBLG | Davis Jason | CFO | BUY | $15K–$50K | 70K | $0.41 | Up 1–2% | Up 7–8% | Mar 3, 2026 |
| LRMR | Flynn James E | Director | BUY | $1M+ | 5.0M | $5.00 | Up 4–5% | Down 5–6% | Mar 3, 2026 |
| GENB | Grous Beth | Chief People Officer | BUY | $1K–$15K | 300 | $16.00 | Down 22–23% | Up 2–3% | Mar 2, 2026 |
| GENB | Silvers Jason | President & CFO | BUY | $15K–$50K | 2K | $16.00 | Down 22–23% | Up 2–3% | Mar 2, 2026 |
| GENB | AFEYAN NOUBAR | Director | BUY | $1M+ | 4.7M | $16.00 | Down 22–23% | Up 2–3% | Mar 2, 2026 |
| GENB | Mendillo Jane L | Director | BUY | $15K–$50K | 2K | $16.00 | Down 22–23% | Up 2–3% | Mar 2, 2026 |
| GENB | AFEYAN NOUBAR | Director | BUY | $1M+ | 4.7M | $16.00 | Down 22–23% | Up 2–3% | Mar 2, 2026 |
| TNC | Glerum James T Jr. | Director | BUY | $100K–$500K | 8K | $61.25 | Up 1–2% | Up 1–2% | Mar 2, 2026 |
| TNC | Mulligan Donal L | Director | BUY | $500K+ | 8K | $63.02 | Down 1–2% | Up 1–2% | Mar 2, 2026 |
| TNC | Huml David W. | PRESIDENT AND CEO | BUY | $100K–$500K | 4K | $64.39 | Down 3–4% | Up 1–2% | Mar 2, 2026 |
| LAW | Srinivasan Krishna | Director | BUY | $100K–$500K | 45K | $3.20 | Up 46–47% | Up 32–33% | Mar 2, 2026 |
| LAW | Friedrichsen Eric | CEO | BUY | $15K–$50K | 16K | $2.90 | Up 61–62% | Up 32–33% | Mar 2, 2026 |
| CTEV | Kim Michael | EVP | BUY | $100K–$500K | 30K | $14.30 | Up 23–24% | Up 22–23% | Mar 2, 2026 |
| NMFC | Boswerger Laura C. Holson | COO | BUY | $50K–$100K | 13K | $7.74 | Up 4–5% | Up 3–4% | Mar 2, 2026 |
| CTEV | Dalton Travis | Pres. | BUY | $100K–$500K | 15K | $13.00 | Up 36–37% | Up 22–23% | Mar 2, 2026 |
| CTEV | O'Neil Tara | SVP, General Counsel | BUY | $1K–$15K | 750 | $12.99 | Up 36–37% | Up 22–23% | Mar 2, 2026 |
| LRMR | Hamilton Thomas Edward | Director | BUY | $500K+ | 100K | $5.00 | Up 4–5% | Down 0–1% | Mar 2, 2026 |
| LRMR | THOMAS FRANK E | Director | BUY | $15K–$50K | 5K | $5.00 | Up 4–5% | Down 0–1% | Mar 2, 2026 |
| LRMR | SHERMAN JEFFREY W | Director | BUY | $15K–$50K | 5K | $5.00 | Up 4–5% | Down 0–1% | Mar 2, 2026 |
| TSLX | Graf Michael | See Remarks | BUY | $15K–$50K | 1K | $18.26 | Up 1–2% | Up 4–5% | Mar 2, 2026 |
| CSGP | FLORANCE ANDREW C | President and CEO | BUY | $1M+ | 56K | $44.52 | Up 9–10% | Up 8–9% | Mar 2, 2026 |
| SXC | Mikhalevsky Andrei Alexander | Director | BUY | $15K–$50K | 5K | $5.53 | Up 13–14% | Up 2–3% | Mar 2, 2026 |
| NFRX | BECKER ROBERT | Insider | BUY | $15K–$50K | 1K | $27.75 | Down 2–3% | Down 2–3% | Mar 2, 2026 |
| COFS | Burke Michael J. Jr. | President | BUY | $1K–$15K | 250 | $28.58 | Down 0–1% | Down 3–4% | Mar 2, 2026 |
| NRGV | Paulson Larry | Director | BUY | $15K–$50K | 5K | $3.15 | Up 6–7% | Up 2–3% | Mar 2, 2026 |
| FBLG | GARCIA RUBEN A | General Counsel | BUY | $1K–$15K | 40K | $0.33 | Up 28–29% | Down 0–1% | Mar 2, 2026 |
| REXR | CLARK LAURA E | COO | BUY | $100K–$500K | 5K | $37.73 | Down 2–3% | — | Feb 28, 2026 |
| REXR | STOCKERT DAVID P | Director | BUY | $100K–$500K | 5K | $37.39 | Down 1–2% | — | Feb 28, 2026 |
| REXR | Fitzmaurice Michael | CFO | BUY | $50K–$100K | 3K | $37.55 | Down 1–2% | — | Feb 28, 2026 |
| HTGC | Theodosopoulos Nikos | Director | BUY | $15K–$50K | 3K | $14.21 | Up 6–7% | Up 6–7% | Feb 27, 2026 |
| SKWD | Robinson Andrew S | Chairman & CEO | BUY | $1M+ | 22K | $46.76 | Up 5–6% | Up 5–6% | Feb 27, 2026 |
| HTGC | BADAVAS ROBERT P | Director | BUY | $50K–$100K | 5K | $14.27 | Up 5–6% | Up 6–7% | Feb 27, 2026 |
| HTGC | Botelho Kiersten Zaza | Chief Legal Office… | BUY | $15K–$50K | 1K | $14.21 | Up 6–7% | Up 6–7% | Feb 27, 2026 |
| HTGC | Fallon Thomas J | Director | BUY | $100K–$500K | 20K | $14.20 | Up 6–7% | Up 6–7% | Feb 27, 2026 |
| HTGC | Meyer Seth H | CFO | BUY | $100K–$500K | 7K | $14.33 | Up 5–6% | Up 6–7% | Feb 27, 2026 |
| HTGC | Bluestein Scott | CEO | BUY | $100K–$500K | 7K | $14.35 | Up 5–6% | Up 6–7% | Feb 27, 2026 |
| OVLY | LAFFERTY ALLISON | Director | BUY | $15K–$50K | 506 | $32.59 | Down 0–1% | Up 1–2% | Feb 27, 2026 |
| POOL | Hope James D | Director | BUY | $100K–$500K | 1K | $213.64 | Up 2–3% | Down 4–5% | Feb 27, 2026 |
| FNWD | Lowry Robert T | Executive Vice Pre… | BUY | $1K–$15K | 51 | $35.56 | Up 2–3% | Down 2–3% | Feb 27, 2026 |
| FNWD | Scheub Todd M. | Executive Vice Pre… | BUY | $1K–$15K | 39 | $35.56 | Up 2–3% | Down 2–3% | Feb 27, 2026 |
🔓Seeing ranges? Sign in for exact trade values — free forever